Leydig, Voit & Mayer, Ltd.
Treatment drug for autoimmune diseases and allergic diseases
The present invention provides an agent for the prophylaxis or therapy of autoimmune diseases or allergic diseases, which contains an anti-Embigin antibody, particularly an anti-Embigin antibody showing cytotoxicity or a cytotoxicity inducing activity, an agent for the prophylaxis or therapy of diseases involving Th17 cell, and a cytotoxic agent to Th17 cell. In addition, an agent for detection of Th17 cell, which contains an anti-Embigin antibody, a convenient detection method of Th17 cell, which uses the agent, a method of efficiently delivering a drug and the like in a Th17 cell selective manner, which uses an anti-Embigin antibody, and a drug delivery system to Th17 cell are provided.
Sumitomo Dainippon Pharma Co., Ltd.
A C A G A G A C G C A A A A A A C
A61K C07K A61P G01N A61K G01N A61P C07K G01N C07K A61P A61P A61P A61P A61P A61P C12Q
inventional inventional inventional inventional additional additional inventional inventional inventional additional inventional inventional inventional inventional inventional inventional inventional
Mitsuhiro Masahito Emi Masunori Toshihiro Koichi
Matsumoto Sugiura Shimizu Kajikawa Kai Kino